Drugs / Streptococcus salivarius 24SMBc + Strept. oralis 89a
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03449836 | Mar → Sep 2018 | allergic disease | Federico II University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Streptococcus salivarius 24SMBc + Strept. oralis 89a | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03449836 ↗ |
| Route | Intranasal | “nasal spray based on Streptococcus salivarius 24SMBc + Strept. oralis 89a” NCT03449836 ↗ |